ALIGNMENT HEALTHCARE INC (ALHC) Stock Fundamental Analysis
USA - NASDAQ:ALHC - US01625V1044 - Common Stock
17.39 USD
+0.27 (+1.58%)
17.39 USD
0 (0%)
Overall ALHC gets a fundamental rating of 3 out of 10. We evaluated ALHC against 101 industry peers in the Health Care Providers & Services industry. ALHC may be in some trouble as it scores bad on both profitability and health. ALHC is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
ALHC had negative earnings in the past year.
ALHC had a positive operating cash flow in the past year.
ALHC had negative earnings in each of the past 5 years.
In multiple years ALHC reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.09%, ALHC is doing worse than 69.31% of the companies in the same industry.
ALHC has a worse Return On Equity (-36.14%) than 72.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.09% | ||
| ROE | -36.14% | ||
| ROIC | N/A |
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALHC has a worse Gross Margin (12.14%) than 71.29% of its industry peers.
In the last couple of years the Gross Margin of ALHC has declined.
ALHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.14% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
2. Health
2.1 Basic Checks
ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALHC has more shares outstanding
ALHC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.64 indicates that ALHC is not in any danger for bankruptcy at the moment.
ALHC's Altman-Z score of 4.64 is fine compared to the rest of the industry. ALHC outperforms 77.23% of its industry peers.
ALHC has a debt to FCF ratio of 11.35. This is a negative value and a sign of low solvency as ALHC would need 11.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.35, ALHC is in line with its industry, outperforming 46.53% of the companies in the same industry.
ALHC has a Debt/Equity ratio of 2.29. This is a high value indicating a heavy dependency on external financing.
ALHC's Debt to Equity ratio of 2.29 is on the low side compared to the rest of the industry. ALHC is outperformed by 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.29 | ||
| Debt/FCF | 11.35 | ||
| Altman-Z | 4.64 |
ROIC/WACCN/A
WACC8.57%
2.3 Liquidity
ALHC has a Current Ratio of 1.66. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
ALHC has a Current ratio of 1.66. This is comparable to the rest of the industry: ALHC outperforms 58.42% of its industry peers.
A Quick Ratio of 1.66 indicates that ALHC should not have too much problems paying its short term obligations.
ALHC's Quick ratio of 1.66 is fine compared to the rest of the industry. ALHC outperforms 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.66 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 66.67% over the past year.
ALHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.46%.
Measured over the past years, ALHC shows a very strong growth in Revenue. The Revenue has been growing by 28.99% on average per year.
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.85%
Revenue 1Y (TTM)49.46%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%49.03%
3.2 Future
Based on estimates for the next years, ALHC will show a very strong growth in Earnings Per Share. The EPS will grow by 33.00% on average per year.
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 26.80% on average per year.
EPS Next Y72.09%
EPS Next 2Y44.15%
EPS Next 3Y36.41%
EPS Next 5Y33%
Revenue Next Year45.64%
Revenue Next 2Y36.79%
Revenue Next 3Y33.38%
Revenue Next 5Y26.81%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
ALHC is valuated quite expensively with a Price/Forward Earnings ratio of 333.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHC indicates a slightly more expensive valuation: ALHC is more expensive than 63.37% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, ALHC is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 333.58 |
4.2 Price Multiples
ALHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALHC is more expensive than 66.34% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALHC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 121.23 | ||
| EV/EBITDA | 623.83 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHC does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALHC's earnings are expected to grow with 36.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.15%
EPS Next 3Y36.41%
5. Dividend
5.1 Amount
ALHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.39
+0.27 (+1.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners74.72%
Inst Owner Change-0.29%
Ins Owners4.2%
Ins Owner Change-2.43%
Market Cap3.44B
Analysts84.44
Price Target19.69 (13.23%)
Short Float %8.82%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)128.24%
Min EPS beat(2)61.17%
Max EPS beat(2)195.32%
EPS beat(4)4
Avg EPS beat(4)69.56%
Min EPS beat(4)3.21%
Max EPS beat(4)195.32%
EPS beat(8)6
Avg EPS beat(8)34.1%
EPS beat(12)9
Avg EPS beat(12)28.2%
EPS beat(16)12
Avg EPS beat(16)24.17%
Revenue beat(2)2
Avg Revenue beat(2)2.98%
Min Revenue beat(2)2.3%
Max Revenue beat(2)3.66%
Revenue beat(4)4
Avg Revenue beat(4)2.52%
Min Revenue beat(4)1.59%
Max Revenue beat(4)3.66%
Revenue beat(8)8
Avg Revenue beat(8)2.72%
Revenue beat(12)11
Avg Revenue beat(12)2.9%
Revenue beat(16)15
Avg Revenue beat(16)3.49%
PT rev (1m)0%
PT rev (3m)4.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.3%
EPS NY rev (1m)0%
EPS NY rev (3m)46.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 333.58 | ||
| P/S | 1.03 | ||
| P/FCF | 121.23 | ||
| P/OCF | 54.47 | ||
| P/B | 24.43 | ||
| P/tB | 33 | ||
| EV/EBITDA | 623.83 |
EPS(TTM)-0.27
EYN/A
EPS(NY)0.05
Fwd EY0.3%
FCF(TTM)0.14
FCFY0.82%
OCF(TTM)0.32
OCFY1.84%
SpS16.85
BVpS0.71
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.09% | ||
| ROE | -36.14% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12.14% | ||
| FCFM | 0.85% |
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
F-Score6
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.29 | ||
| Debt/FCF | 11.35 | ||
| Debt/EBITDA | 63.32 | ||
| Cap/Depr | 119.42% | ||
| Cap/Sales | 1.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 1242.14% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.66 | ||
| Altman-Z | 4.64 |
F-Score6
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)151.69%
Cap/Depr(5y)136.01%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.85%
EPS Next Y72.09%
EPS Next 2Y44.15%
EPS Next 3Y36.41%
EPS Next 5Y33%
Revenue 1Y (TTM)49.46%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%49.03%
Revenue Next Year45.64%
Revenue Next 2Y36.79%
Revenue Next 3Y33.38%
Revenue Next 5Y26.81%
EBIT growth 1Y81.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.94%
EBIT Next 3Y58.66%
EBIT Next 5Y46.72%
FCF growth 1Y-42.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.15%
OCF growth 3YN/A
OCF growth 5Y30.43%